These data represent the 2282 commercial clinical samples that were used in the initial study discovery.

These samples were collected between October 2014 and October 2016 and were genotyped based on ethnicity (77 for Cau; 75 for AA; 71 for His). The original commercial model incorporated the Gail model +PRS (for which 5 year and lifetime risk score can be found in column O and P; calculated per Dite, 2016). The Gail model risk scores alone can be found in columns M and N. The Streamlined model plus PRS risk scores are in columns Q and R. The polygenic risk scores are in column L were calculated per Mealiffe 2010. The clinical Gail model questions can be found in columns D-K, respectively: current age; age at menarche, age at 1st live birth; previous biopsy; number of previous biopsies; confirmed atypical hyperplasia; ethnicity.
(XLSX)

本数据集的样本采集于2014年10月至2016年10月期间，依据种族进行基因分型：高加索人（Caucasian, Cau）77例、非裔美国人（African American, AA）75例、西班牙裔（Hispanic, His）71例。
原始商用模型整合了Gail模型（Gail model）与多基因风险评分（Polygenic Risk Score, PRS），其中5年风险评分与终生风险评分可于O、P列查询，该评分依据Dite等人2016年的研究方法计算得到。
仅使用Gail模型计算的风险评分可见于M、N列。
精简模型结合多基因风险评分的结果位于Q、R列。
列L中的多基因风险评分依据Mealiffe 2010年的研究方法计算得到。
临床Gail模型相关调研问题依次分布于D至K列，分别为：当前年龄、月经初潮年龄、首胎活产年龄、既往乳腺活检史、既往活检次数、确诊不典型增生、种族。
(XLSX)